A New Platform for Delivering Therapeutics Using Extracellular Vesicles
Author Information
Author(s): Martin Perez Carla, Liang Xiuming, Gupta Dhanu, Haughton Emily R., Conceição Mariana, Mäger Imre, EL Andaloussi Samir, Wood Matthew J.A., Roberts Thomas C.
Primary Institution: University of Oxford
Hypothesis
Can PTTG1IP protein enhance the loading and delivery of therapeutic cargo in extracellular vesicles?
Conclusion
PTTG1IP is an effective scaffold for loading and delivering therapeutic proteins via extracellular vesicles.
Supporting Evidence
- PTTG1IP was shown to enhance the loading of Cre protein into extracellular vesicles.
- The study demonstrated that PTTG1IP can be engineered for improved therapeutic delivery.
- In vivo experiments showed successful delivery of Cre recombinase using PTTG1IP-based extracellular vesicles.
Takeaway
Scientists found a new way to use a protein called PTTG1IP to help tiny bubbles called extracellular vesicles carry medicine to cells better.
Methodology
The study used bioinformatics analysis to identify protein features and tested the loading efficiency of PTTG1IP in various cell lines.
Limitations
The study primarily focused on in vitro experiments, and further in vivo studies are needed to confirm the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website